Supplementary Files
How to Cite
Abstract
Abstract:
Background: Drug adherence to medications in diabetes is very necessary for strict glycemic control. Many factors in diabetics are associated with low adherence to drugs resulting in complications.
Methods: This research was conducted as an observational study with cross-sectional study design. It was scheduled between July 2022 to December 2022 in medical outpatient department of Combined Military Hospital, Peshawar
Results: 115 individuals were inducted over a period of 6 months from medical OPD ex Combined Military Hospital Peshawar. Five patients failed to follow-up with research team resulting in a total of 110 participants included in results. Average age across the study sample was 50.25 ± 11.97 years with 58 (52.73%) males and 52 (47.27%) females. Most participant in our study sample were educated up to matriculation with BMI <25kg/m2.
Average duration of diabetes across the sample was 6.1 ± 3.69 years. In treatment options, 53 (48.18%) individuals were only managed with oral therapy, 16 (14.55%) on insulin only while 41 (37.27%) were prescribed with both oral hypoglycemic drugs and insulin. Most common comorbid across study population was hypertension, seen in 59 (53.94%) diabetic patients, followed by cataract in 41 (37.47%) and IHD in 33 (30%) patients.
In all 110 individuals, only 29 (26.36%) individuals had good glycemic control i.e., HbA1c <7% with average glycosylated hemoglobin percentage measuring 8.29% ± 1.59%. As per MMAS-8 score, 25 (22.73%) patients reported good adherence, 31 (28.18%) patients reported fair adherence while rest 54 (49.09%) were found to have bad adherence. Average MMAS-8 score was 5.17.
Conclusion: There is a correlation between medication adherence as measured by MMAS-8 score with control of diabetes as measured by HbA1c score in the range of 1.824% across the range of MMAS-8 score from 0-8. Sleep quality, BMI and multiple comorbid conditions were also linked with raised HbA1c.
Key words: Drug adherence, Morisky Medication Adherence Scale, Diabetes, Non-diabetes, diabetic medications
References
Non communicable diseases [Internet]. [cited 2023 Jan 25]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
HealthPayerIntelligence. Top 10 Most Expensive Chronic Diseases for Healthcare Payers [Internet]. HealthPayerIntelligence. 2022 [cited 2023 Jan 25]. Available from: https://healthpayerintelligence.com/news/top-10-most-expensive-chronic-diseases-for-healthcare-payers
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. N Engl J Med. 2009 Jan 8;360(2):129–39.
Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med. 2008 Jun 12;358(24):2545–59.
Heller SR, ADVANCE Collaborative Group. A summary of the ADVANCE Trial. Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S357-361.
Holman R. brief history of the UK Prospective Diabetes Study: RURY R HOLMAN, FOR THE UKPDS GROUP. Br J Diabetes. 2022 Dec 22;22(Supplement 1):S32–5.
Mogre V, Johnson NA, Tzelepis F, Shaw JE, Paul C. A systematic review of adherence to diabetes self-care behaviours: Evidence from low- and middle-income countries. J Adv Nurs. 2019;75(12):3374–89.
Baghikar S, Benitez A, Fernandez Piñeros P, Gao Y, Baig AA. Factors Impacting Adherence to Diabetes Medication Among Urban, Low Income Mexican-Americans with Diabetes. J Immigr Minor Health. 2019 Dec 1;21(6):1334–41.
Hussain N, Said ASA, Khan Z. Influence of Health Literacy on Medication Adherence Among Elderly Females With Type 2 Diabetes in Pakistan. Int Q Community Health Educ. 2020 Oct;41(1):35–44.
Soraya IA, Sauriasari R, Prawiroharjo P, Risni HW. The Association between Adherence to Oral Antihyperglycemic Agent and HbA1c Level. Pharm Sci Res [Internet]. 2022 Aug 1 [cited 2022 Dec 30];9(2). Available from: https://scholarhub.ui.ac.id/psr/vol9/iss2/4/
Naqvi AA, Hassali MA, Rizvi M, Zehra A, Nisa ZU, Islam MA, et al. Validation of the General Medication Adherence Scale in Pakistani Patients With Rheumatoid Arthritis. Front Pharmacol. 2020;11:1039.
Sartorius N. Depression and diabetes. Dialogues Clin Neurosci. 2018 Mar;20(1):47–52.
Khan AA, Marwat SK, Noor MM, Fatima S. RELIABILITY AND VALIDITY OF BECK DEPRESSION INVENTORY AMONG GENERAL POPULATION IN KHYBER PAKHTUNKHWA, PAKISTAN. J Ayub Med Coll Abbottabad JAMC. 2015;27(3):573–5.
Biracyaza E, Habimana S, Rusengamihigo D. Psychometric Properties of the Beck Depression Inventory (BDI-II) in Cancer Patients: Cancer Patients from Butaro Ambulatory Cancer Center, Rwanda. Psychol Res Behav Manag. 2021;14:665–74.
Azeem S, Khan U, Liaquat A. The increasing rate of diabetes in Pakistan: A silent killer. Ann Med Surg 2012. 2022 Jul;79:103901.
Butt MD, Ong SC, Wahab MU, Rasool MF, Saleem F, Hashmi A, et al. Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings from a Lower-Middle Income Country. Int J Environ Res Public Health. 2022 Oct 2;19(19):12611.
Tominaga Y, Aomori T, Hayakawa T, Morisky DE, Takahashi K, Mochizuki M. Relationship between medication adherence and glycemic control in Japanese patients with type 2 diabetes. Pharm - Int J Pharm Sci. 2018 Oct 1;73(10):609–12.
Wong MCS, Wu CHM, Wang HHX, Li HW, Hui EMT, Lam AT, et al. Association between the 8-item Morisky medication adherence scale (MMAS-8) score and glycaemic control among Chinese diabetes patients. J Clin Pharmacol. 2015;55(3):279–87.
Wolever RQ, Dreusicke M, Fikkan J, Hawkins TV, Yeung S, Wakefield J, et al. Integrative Health Coaching for Patients With Type 2 Diabetes. Diabetes Educ. 2010 Jul 1;36(4):629–39.
Arora S, Peters AL, Burner E, Lam CN, Menchine M. Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial. Ann Emerg Med. 2014 Jun 1;63(6):745-54.e6.
Bogner HR, Morales KH, Vries HF de, Cappola AR. Integrated Management of Type 2 Diabetes Mellitus and Depression Treatment to Improve Medication Adherence: A Randomized Controlled Trial. Ann Fam Med. 2012 Jan 1;10(1):15–22.
Nesari M, Zakerimoghadam M, Rajab A, Bassampour S, Faghihzadeh S. Effect of telephone follow-up on adherence to a diabetes therapeutic regimen. Jpn J Nurs Sci. 2010;7(2):121–8.
Alkhoshaiban A, Hassan Y, Loganathan M, Alomary M, Morisky DE, Alawwad B. Type II Diabetic Patients’ Satisfaction, Medication Adherence, and Glycemic Control after the Application of Pharmacist Counseling Program. Arch Pharm Pract. 2019;10(4).
Mirahmadizadeh A, Khorshidsavar H, Seif M, Sharifi MH. Adherence to Medication, Diet and Physical Activity and the Associated Factors Amongst Patients with Type 2 Diabetes. Diabetes Ther. 2020 Feb;11(2):479–94.
Jannoo Z, Mamode Khan N. Medication Adherence and Diabetes Self-Care Activities Among Patients With Type 2 Diabetes Mellitus. Value Health Reg Issues. 2019 May 1;18:30–5.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2023 Bilal Saeed, Fuad Ahmad Siddiqi, Mehmood Hussain, Wasif Anwar, Sidra Riaz, Naveed Abbas